Femasys (FEMY) Return on Invested Capital (2024 - 2025)

Femasys (FEMY) posted Return on Invested Capital of 0.03% for Q2 2025, up 3.18% on a QoQ basis from 0.03% in Q1 2025, and little changed year-over-year from 0.03% in Q2 2024.

Femasys (FEMY) Return on Invested Capital (2024 - 2025) Analysis & Trends

Femasys' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.03% for Q2 2025.

  • Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.03% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.03% (changed 0.0% YoY) and the FY2024 annual result came in at 0.03%, changed N/A from the prior year.
  • Return on Invested Capital was 0.03% for Q2 2025 at Femasys, up from 0.03% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.02% in Q1 2024 and bottomed at 0.03% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 0.00%
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 0.02%
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 0.00%
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 0.12%
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Femasys 17.46 Mn 12.07 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -0.03%
Mar 31, 2025 -0.03%
Dec 31, 2024 -0.03%
Sep 30, 2024 -0.03%
Jun 30, 2024 -0.02%
Mar 31, 2024 -0.02%